Signup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. FDA Announces First Approved Mito Therapy: Forzinity...
Read moreUMDF celebrates historic milestone for rare disease community The United Mitochondrial Disease Foundation (UMDF), the largest mitochondrial...
Read moreToday marks the official kickoff of World Mitochondrial Disease Week, a time designed to help the public better understand mitochondrial...
Read moreSignup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. UMDF Preps for Mitochondrial Disease Awareness Week...
Read moreSept. 4, 2025 — Earlier today, Saol Therapeutics shared the U.S. Food and Drug Administration (FDA) has issued a Complete Response...
Read moreSignup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. ...
Read moreWe’re excited to unite with other mitochondrial disease-focused patient advocacy groups across the globe to spread awareness on World...
Read moreBarth Syndrome Foundation, UMDF, and MitoAction leadership were recently notified by Stealth BioTherapeutics that FDA has refused their request...
Read moreSignup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. The Mito Fund Announces Investment in Pretzel...
Read more